Selected articles & press releases
Five advantages of PET in diagnostic imaging
Positron Emission Tomography (PET) is a common medical imaging technique with several advantages over X-ray, computed tomography (CT), and magnetic resonance imaging (MRI), particularly in diagnosing and monitoring diseases at the molecular level. One-minute YouTube summary here.
The Evolution of Medical Imaging: From X-Rays to AI-Driven Diagnostics
A brief overview of the history and evolution of medical imaging techniques: ultrasound, x-ray, CT, MRI, and PET imaging. Also, what’s next: Artificial Intelligence/Machine Learning. Two-minute YouTube summary here.
AI (still) isn’t a magic bullet for drug discovery
AI alone cannot solve the complex challenges in this field due to limited training data, incomplete understanding of pathology, and the vastness of unexplored chemical compounds. Two-minute YouTube summary here.
Braxton Norwood’s Pioneering Work with PET Imaging
Positron emission tomography, or PET, is a powerful technique that permits researchers to form images of activity occurring inside the brain. Taking advantage of specially designed radiotracers that can selectively link up with specific neurotransmitters or receptors involved in epileptic activity, PET scans are similar to shining a spotlight into the intricate workings of the brain.
Scientist-Entrepreneur Launches Unbreakables Foundation to Empower Single Mothers and Children
Unbreakables is a newly minted 501(c)(3) nonprofit with a laser focus on empowering disadvantaged families, particularly single mothers and children. Dr. Braxton Norwood’s vision is clear: “Our foundation will use donations to fund education, training, and childcare for single parents, who face unique challenges.”
Unbreakables Foundation of Montana Announces Key Initiatives and Programs
Unbreakables Foundation’s Key Initiatives and Programs include: Educational and Training Programs, Childcare Services, and Collaborative Efforts
Unbreakables Foundation: Improving Self-Reliance For Disadvantaged Families
Unbreakables Foundation proudly announces the approval of its nonprofit tax-exempt status by the IRS. “We believe that everyone deserves the opportunity for a bright, independent future. In particular, single mothers and children, who tend to be the most disadvantaged.” — Braxton Norwood, co-founder
Winner of AAPM-MIT Hacking Medicine Innovation Challenge Lutroo Imaging
“Lutroo Imaging emerged victorious among 70 competing startups and early-stage companies, securing the top honors at the inaugural American Academy of Pain Medicine (AAPM) and MIT Hacking Medicine Innovation Challenge presented by Abbott.”
AAPM 2022: Clinician Perspective
Grand prize winner Lutroo Imaging presented a patented PET radiotracer that enables pain visualization and objective quantification for diagnosis and pain therapy research and development.
Company receives SBIR award from the National Institutes of Health’s HEAL Initiative to develop an objective pain measurement tool
“‘We’re honored to be part of the HEAL Initiative,’ said Dr. Braxton Norwood, Principal Investigator and CEO.”
CURE Epilepsy Research Continuity Fund: Modeling Drug – Refractory Epilepsy With the KaL Method
“Dr. Braxton Norwood and his team [were] developing two novel laboratory models of drug-resistant human epilepsy, which will be used to discover and develop next-generation epilepsy therapies.”
Flathead Montana neuroscience researchers awarded $1.4M grant
“CEO Braxton Norwood said the grant will be vital in helping the fast-growing company develop therapeutic and imaging agents for neurological disorders.”
Montana company Receives Fast-Track SBIR Grant From The National Institutes Of Health
“We’re very excited about this funding and greatly appreciate the NIH’s support,’ said Braxton Norwood, PhD Principal Investigator and CEO.”
Montana epilepsy researchers awarded $100,000 grant
“Kalispell neuroscience researchers received a $101,250 grant from the Montana Department of Commerce to aid their search for better treatment for epilepsy and other neurodegenerative conditions.”
2014 CURE Epilepsy Challenge Award, Funded by the CJM Foundation
This $250,000 award seeks to push the envelope and accelerate promising research leading to disease-modifying breakthroughs for people living with epilepsy. CURE prioritizes highly innovative, risky, paradigm-shifting projects that address CURE’s mission to cure epilepsy.